One-year antibody persistence and safety of a 4-dose schedule of MenACWY-CRM in healthy infants from South Korea

PURPOSE: Results from a post-marketing study to generate evidence on 1-year antibody persistence and safety following vaccination of infants from South Korea with the quadrivalent meningococcal conjugate vaccine MenACWY-CRM. MATERIALS AND METHODS: In this phase IV, open-label, multi-center study (NC...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Hoan-Jong, Jo, Dae Sun, Kim, Yun-Kyung, Lee, Hyunju, Kim, Kyung-Hyo, Lee, Dokyung, Curina, Carlo, Costantini, Marco, Barbi, Silvia, Miao, Yan, Pellegrini, Michele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Vaccine Society 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6689500/
https://www.ncbi.nlm.nih.gov/pubmed/31406690
http://dx.doi.org/10.7774/cevr.2019.8.2.94

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6689500/
https://www.ncbi.nlm.nih.gov/pubmed/31406690
http://dx.doi.org/10.7774/cevr.2019.8.2.94

Ejemplares similares